Tag Archive: biomimetic

Nov 16

Nallathamby Lab is one of 20 Participants Invited to Present Phage-Mimicking Antibacterial Nanoparticle Prototype at the Inaugural Joint Innovation Medical Symposium (JIMS) at Pope Army Airfield/Fort Bragg (Nov 16-17, 2022)

In recent combat theaters, despite advances in treating critical injuries leading to higher survival rates, there has been an increase in the number of infections linked to trauma, particularly those caused by bacteria resistant to multiple drugs 1,2.  Research from the Trauma Infectious Disease Outcomes Study indicates that 27% of those evacuated with injuries develop …

Continue reading »

May 14

Nallathamby Lab Presents Novel Antibacterial and Novel Chemotherapeutics Work at MRS 2022 Spring Meeting (May 8-13, 2022| Honolulu, Hawai’i)

Our research looks at the basic mechanism of drug resistance in bacteria or cancer cells and then we work on translational solutions to combat these problems. Our approach felt validated at this meeting where we networked with industry end-users as well as disease-on-a chip modeling academicians.